Merck & Co,with research and development chief Roger Perlmutter, will begin to focus increasingly more…
J. Lewis Research, Inc.September 11, 2013
Over the past decade, only 3.8% of newly approved drugs have been created for neglected diseases. These include tuberculosis, tropical…
J. Lewis Research, Inc.December 20, 2012
